Image

Impact of a Physical Exercise Program on the Self-care Capacity of People Hospitalized for Heart Failure

Impact of a Physical Exercise Program on the Self-care Capacity of People Hospitalized for Heart Failure

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The objective of the study is to evaluate the effectiveness of a self-care program that integrates physical exercise with components of aerobic and muscular strength training in improving functional capacity and muscular strength in people hospitalized for decompensated heart failure, in a clinical stabilization phase

The main question it aims to answer is:

Is the Self-care program that integrates physical exercise with aerobic and muscular strength training components effective in improving the capacity for self-care in people hospitalized for decompensated HF, in the clinical stabilization phase?

In this randomized clinical trial, the Self-Care program will be applied in the experimental group. The ERIC-HF program will be applied in the control group. The ERIC-HF is a program of exercise only with an aerobic component.

Participants will complete these programs during their hospital stay and various assessment instruments (quality of life, functional capacity, capacity for self-care, muscle strength) will be applied at admission, at discharge and one month after discharge.

Eligibility

Inclusion Criteria:

  • Participants: Clinical diagnosis of decompensated HF, regardless of etiology or ventricular function;
  • Participants: Be over 18 years old;
  • Participants: Be able to provide informed consent.

Exclusion Criteria (participants):

  • Osteoarticular pathology that causes physical limitations that prevent the performance of physical exercise;
  • Existence of intravenous inotropic medication;
  • Uncontrolled auricular or ventricular arrhythmias;
  • Chest pain in the last 8 hours;
  • Heart rate greater than 120;
  • Dyspnea at rest;
  • Uncontrolled blood pressure - Systolic blood pressure greater than 180mmHg or diastolic blood pressure greater than 110mmHg;
  • 2nd or 3rd degree atrioventricular block;
  • Oxygen need at a rate greater than 3L/min;
  • Glycemic decompensation in the last 12 hours.

Study details
    Heart Failure

NCT06528561

Centro Hospitalar Universitário de Santo António

21 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.